Actinium Pharmaceuticals Inc. (Delaware) (ATNM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Actinium Pharmaceuticals Inc. (Delaware), updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Actinium Pharmaceuticals Inc. (Delaware) (ATNM) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $45M. It trades at $1.38, down 2.82% today, at 3.9 times earnings. Its overall quality score is 74 out of 100, ranked against the whole US market. 2 analysts' average target of $3.50 implies +153.6% from today's price. Kronos AI's 30-day forecast is −25.5% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.50 |
| Low – high | $3.00 – $4.00 |
| Analysts | 2 |
| Upside to average | +153.6% |
Kronos AI 30-day forecast
| Expected close | $1.06 (−25.5%) |
| Likely range | −26.8% … −22.8% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 89 |
| Solvency | 91 |
| Growth | 42 |
| Overall | 74 |
| P/E | 3.9 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator